SCHEMBL17464281

SCHEMBL17464281

CB(O)N1CCC(C)C(CO)C1

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL17464283 0.85 — —
SCHEMBL12872848 0.75 TDP1 (0.31) —
SCHEMBL15691793 0.72 NCF1 (0.37) —
SCHEMBL7990665 0.72 NCF1 (0.37) —
SCHEMBL19154844 0.71 — —
SCHEMBL13389359 0.71 CA1 (0.34) —
SCHEMBL10202916 0.70 — —
SCHEMBL13286237 0.69 GBA1 (0.38) —
SCHEMBL14071752 0.69 GBA1 (0.38) —
SCHEMBL12129040 0.69 CHRNA7 (0.31) —

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20160024121-A1 BETA-LACTAMASE INHIBITORS VenatoRx Pharmaceuticals, Inc. 2016-01-28 — — US disclosed
Send feedback